Beckman CEO Resigns As Company Faces Regulatory Challenges
This article was originally published in The Gray Sheet
Executive Summary
Beckman Coulter announced the resignation of Scott Garrett as chairman, president and CEO Sept. 7 as the firm tries to recover from a recent FDA-triggered diagnostic test market withdrawal and ongoing regulatory scrutiny